SEC Form 4 · accession 0000899243-16-026824
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Khadder
Officer — See Remarks
Period of report
Aug 9, 2016
Accepted (ET)
Aug 11, 2016 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Aug 9, 2016 | A | 10,800 | A | — | — | Common Stock | 10,800 | 10,800 | D |
| Employee Stock Option (Right to Buy)F3 | $9.05 | Aug 9, 2016 | A | 27,000 | A | — | Aug 9, 2026 | Common Stock | 27,000 | 27,000 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
- F214/48th of the total number of shares underlying the Restricted Stock Units granted will vest on August 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through each applicable vest date.
- F312/48th of the total number of shares subject to the Option will vest on June 20, 2017 and 1/48th of the total shares subject to the Option will vest and become exercisable each month thereafter over the succeeding 36 months, such that the Option will be fully vested on June 20, 2020, subject to the recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through each applicable vest date.
Remarks
Senior Vice President, Legal Affairs, General Counsel, Chief Compliance Officer and Secretary